Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Ice thickness data in the northern sea route (NSR) for the period 2006-2016.

Cheaitou A, Faury O, Cariou P, Hamdan S, Fabbri G.

Data Brief. 2019 Apr 16;24:103925. doi: 10.1016/j.dib.2019.103925. eCollection 2019 Jun.

2.

Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice.

Alteri C, Scutari R, Bertoli A, Armenia D, Gori C, Fabbri G, Mastroianni CM, Cerva C, Cristaudo A, Vicenti I, Bruzzone B, Zazzi M, Andreoni M, Antinori A, Svicher V, Ceccherini-Silberstein F, Perno CF, Santoro MM.

Virus Genes. 2019 Jun;55(3):290-297. doi: 10.1007/s11262-019-01649-z. Epub 2019 Feb 22.

PMID:
30796743
3.

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age.

Bongiovanni A, Recine F, Foca F, Fausti V, Riva N, Fabbri G, Severi S, Liverani C, De Vita A, Spadazzi C, Miserocchi G, Mercatali L, Amadori D, Ibrahim T.

Endocr Connect. 2018 Dec 1. pii: EC-18-0478.R1. doi: 10.1530/EC-18-0478. [Epub ahead of print]

4.
5.

Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.

Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, Quarta CC, Taborchi G, Bartolini S, Frusconi S, Martone R, Cinelli MM, Foffi S, Reggiani MLB, Fabbri G, Cataldo P, Cappelli F, Rapezzi C.

Eur J Heart Fail. 2018 Oct;20(10):1417-1425. doi: 10.1002/ejhf.1285. Epub 2018 Aug 2.

PMID:
30070416
6.

Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.

Gulizia MM, Cemin R, Colivicchi F, De Luca L, Di Lenarda A, Boriani G, Di Pasquale G, Nardi F, Scherillo M, Lucci D, Fabbri G, Maggioni AP; BLITZ-AF Investigators.

Europace. 2019 Feb 1;21(2):230-238. doi: 10.1093/europace/euy166.

PMID:
30060174
7.

Liver stiffness reduction and serum fibrosis score improvement in HIV/hepatitis C virus-coinfected patients treated with direct-acting antivirals.

Fabbri G, Mastrorosa I, Vergori A, Timelli L, Lorenzini P, Zaccarelli M, Cicalini S, Bellagamba R, Plazzi MM, Mazzotta V, Antinori A, Ammassari A.

HIV Med. 2018 Jun 28. doi: 10.1111/hiv.12632. [Epub ahead of print]

PMID:
29953713
8.

Increasing the Vertical Dimension of Occlusion: A Multicenter Retrospective Clinical Comparative Study on 100 Patients with Fixed Tooth-Supported, Mixed, and Implant-Supported Full-Arch Rehabilitations.

Fabbri G, Sorrentino R, Cannistraro G, Mintrone F, Bacherini L, Turrini R, Bombardelli T, Nieri M, Fradeani M.

Int J Periodontics Restorative Dent. 2018 May/Jun;38(3):323-335. doi: 10.11607/prd.3295.

PMID:
29641621
9.

UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.

Notari S, Tempestilli M, Fabbri G, Libertone R, Antinori A, Ammassari A, Agrati C.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 15;1073:183-190. doi: 10.1016/j.jchromb.2017.12.018. Epub 2017 Dec 12.

PMID:
29276983
10.

Somatic CLL mutations occur at multiple distinct hematopoietic maturation stages: documentation and cautionary note regarding cell fraction purity.

Marsilio S, Khiabanian H, Fabbri G, Vergani S, Scuoppo C, Montserrat E, Shpall EJ, Hadigol M, Marin P, Rai KR, Rabadan R, Devereux S, Pasqualucci L, Chiorazzi N.

Leukemia. 2018 Apr;32(4):1041-1044. doi: 10.1038/leu.2017.343. Epub 2017 Dec 5. No abstract available.

11.

Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world.

Tempestilli M, Fabbri G, Mastrorosa I, Timelli L, Notari S, Bellagamba R, Libertone R, Lupi F, Zaccarelli M, Antinori A, Agrati C, Ammassari A.

J Antimicrob Chemother. 2018 Jan 1;73(1):160-164. doi: 10.1093/jac/dkx348.

PMID:
29106584
12.

Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals.

Rozera G, Fabbri G, Lorenzini P, Mastrorosa I, Timelli L, Zaccarelli M, Amendola A, Vergori A, Plazzi MM, Cicalini S, Antinori A, Capobianchi MR, Abbate I, Ammassari A.

PLoS One. 2017 Oct 27;12(10):e0187095. doi: 10.1371/journal.pone.0187095. eCollection 2017.

13.

Prevalence and determinants of oral infection by Human Papillomavirus in HIV-infected and uninfected men who have sex with men.

Rollo F, Latini A, Pichi B, Colafigli M, Benevolo M, Sinopoli I, Sperduti I, Laquintana V, Fabbri G, Frasca M, Cristaudo A, Giuliani M, Donà MG.

PLoS One. 2017 Sep 14;12(9):e0184623. doi: 10.1371/journal.pone.0184623. eCollection 2017.

14.

Evaluation of the Xpert® HPV assay in the detection of Human Papillomavirus in formalin-fixed paraffin-embedded oropharyngeal carcinomas.

Donà MG, Rollo F, Pichi B, Spriano G, Pellini R, Covello R, Pescarmona E, Fabbri G, Scalfari M, Gheit T, Benevolo M.

Oral Oncol. 2017 Sep;72:117-122. doi: 10.1016/j.oraloncology.2017.07.016.

PMID:
28797447
15.

In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals.

Tumino N, Casetti R, Fabbri G, Cimini E, Romanelli A, Turchi F, Forini O, Bordoni V, Antinori A, Ammassari A, Sacchi A, Agrati C.

J Hepatol. 2017 Aug;67(2):422-424. doi: 10.1016/j.jhep.2017.03.036. Epub 2017 Apr 12. No abstract available.

PMID:
28411041
16.

Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia.

Fabbri G, Holmes AB, Viganotti M, Scuoppo C, Belver L, Herranz D, Yan XJ, Kieso Y, Rossi D, Gaidano G, Chiorazzi N, Ferrando AA, Dalla-Favera R.

Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):E2911-E2919. doi: 10.1073/pnas.1702564114. Epub 2017 Mar 17.

17.

Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.

Fabbri G, Mastrorosa I, Vergori A, Mazzotta V, Pinnetti C, Grisetti S, Zaccarelli M, Ammassari A, Antinori A.

BMC Infect Dis. 2017 Mar 1;17(1):182. doi: 10.1186/s12879-017-2287-y. Review.

18.

Clinical Evaluation of the Influence of Connection Type and Restoration Height on the Reliability of Zirconia Abutments: A Retrospective Study on 965 Abutments with a Mean 6-Year Follow-Up.

Fabbri G, Fradeani M, Dellificorelli G, De Lorenzi M, Zarone F, Sorrentino R.

Int J Periodontics Restorative Dent. 2017 Jan/Feb;37(1):19-31. doi: 10.11607/prd.2974.

PMID:
27977814
19.

Epidemiology of Heart Failure.

Orso F, Fabbri G, Maggioni AP.

Handb Exp Pharmacol. 2017;243:15-33. doi: 10.1007/164_2016_74. Review.

PMID:
27718059
20.

The molecular pathogenesis of chronic lymphocytic leukaemia.

Fabbri G, Dalla-Favera R.

Nat Rev Cancer. 2016 Mar;16(3):145-62. doi: 10.1038/nrc.2016.8. Review.

PMID:
26911189
21.

Upstream Treatment of Atrial Fibrillation with n-3 Polyunsaturated Fatty Acids: Myth or Reality?

Orso F, Fabbri G, Maggioni AP.

Arrhythm Electrophysiol Rev. 2015 Dec;4(3):163-8. doi: 10.15420/aer.2015.4.3.163. Epub 2015 Dec 1.

22.

Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia.

Wang J, Khiabanian H, Rossi D, Fabbri G, Gattei V, Forconi F, Laurenti L, Marasca R, Del Poeta G, Foà R, Pasqualucci L, Gaidano G, Rabadan R.

Elife. 2014 Dec 11;3. doi: 10.7554/eLife.02869.

23.

Post-marketing surveillance of CustomBone Service implanted in children under 7 years old.

Frassanito P, Tamburrini G, Massimi L, Di Rocco C, Nataloni A, Fabbri G, Caldarelli M.

Acta Neurochir (Wien). 2015 Jan;157(1):115-21. doi: 10.1007/s00701-014-2254-y. Epub 2014 Oct 19.

PMID:
25326712
24.

A novel approach to implant screw-retained restorations: adhesive combination between zirconia frameworks and monolithic lithium disilicate.

Fabbri G, Sorrentino R, Brennan M, Cerutti A.

Int J Esthet Dent. 2014 Winter;9(4):490-505.

PMID:
25289384
25.

Postinduction minimal residual disease monitoring by polymerase chain reaction in children with acute lymphoblastic leukemia.

Paganin M, Fabbri G, Conter V, Barisone E, Polato K, Cazzaniga G, Giraldi E, Fagioli F, Aricò M, Valsecchi MG, Basso G.

J Clin Oncol. 2014 Nov 1;32(31):3553-8. doi: 10.1200/JCO.2014.56.0698. Epub 2014 Oct 6.

PMID:
25287825
26.

Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia.

Trimarchi T, Bilal E, Ntziachristos P, Fabbri G, Dalla-Favera R, Tsirigos A, Aifantis I.

Cell. 2014 Jul 31;158(3):593-606. doi: 10.1016/j.cell.2014.05.049.

27.

Newest additions to heart failure treatment.

Orso F, Fabbri G, Baldasseroni S, Maggioni AP.

Expert Opin Pharmacother. 2014 Sep;15(13):1849-61. doi: 10.1517/14656566.2014.934812. Epub 2014 Jul 3. Review.

PMID:
24989872
28.

Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.

Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators.

J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110.

PMID:
24978662
29.

Clinical evaluation of 860 anterior and posterior lithium disilicate restorations: retrospective study with a mean follow-up of 3 years and a maximum observational period of 6 years.

Fabbri G, Zarone F, Dellificorelli G, Cannistraro G, De Lorenzi M, Mosca A, Sorrentino R.

Int J Periodontics Restorative Dent. 2014 Mar-Apr;34(2):165-77. doi: 10.11607/prd.1769.

PMID:
24600653
30.

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness.

Messina M, Del Giudice I, Khiabanian H, Rossi D, Chiaretti S, Rasi S, Spina V, Holmes AB, Marinelli M, Fabbri G, Piciocchi A, Mauro FR, Guarini A, Gaidano G, Dalla-Favera R, Pasqualucci L, Rabadan R, Foà R.

Blood. 2014 Apr 10;123(15):2378-88. doi: 10.1182/blood-2013-10-534271. Epub 2014 Feb 18.

31.

Cervicoscopy and Microcolposcopy in the Evaluation of Squamo Columnar Junction and Cervical Canal in LSIL Patients with Inadequate or Negative Colposcopy.

Valli E, Fabbri G, Centonze C, Bompiani A, Baiocco F, Larciprete G, Ghinassi A.

Int J Biomed Sci. 2013 Sep;9(3):148-52.

32.

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.

Fabbri G, Khiabanian H, Holmes AB, Wang J, Messina M, Mullighan CG, Pasqualucci L, Rabadan R, Dalla-Favera R.

J Exp Med. 2013 Oct 21;210(11):2273-88. doi: 10.1084/jem.20131448. Epub 2013 Oct 14.

33.

Recurrent miscarriage and cervical human papillomavirus infection.

Ticconi C, Pietropolli A, Fabbri G, Capogna MV, Perno CF, Piccione E.

Am J Reprod Immunol. 2013 Nov;70(5):343-6. doi: 10.1111/aji.12156. Epub 2013 Sep 16.

PMID:
24102829
34.

Clinical reliability of CAD/CAM cross-arch zirconia bridges on immediately loaded implants placed with computer-assisted/template-guided surgery: a retrospective study with a follow-up between 3 and 5 years.

Pozzi A, Holst S, Fabbri G, Tallarico M.

Clin Implant Dent Relat Res. 2015 Jan;17 Suppl 1:e86-96. doi: 10.1111/cid.12132. Epub 2013 Aug 5.

PMID:
23910539
35.

n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.

Aleksova A, Masson S, Maggioni AP, Lucci D, Fabbri G, Beretta L, Mos L, Paino AM, Nicolosi GL, Marchioli R, Tognoni G, Tavazzi L, Sinagra G, Latini R; GISSI-Heart Failure Investigators.

Eur J Heart Fail. 2013 Nov;15(11):1289-95. doi: 10.1093/eurjhf/hft103. Epub 2013 Jul 9.

36.

Decision making for oral anticoagulants in atrial fibrillation: the ATA-AF study.

Gussoni G, Di Pasquale G, Vescovo G, Gulizia M, Mathieu G, Scherillo M, Panuccio D, Lucci D, Nozzoli C, Fabbri G, Colombo F, Riva L, Baldo CI, Maggioni AP, Mazzone A; ATA-AF Steering Committee and Investigators.

Eur J Intern Med. 2013 Jun;24(4):324-32. doi: 10.1016/j.ejim.2013.04.008. Epub 2013 May 16.

PMID:
23684591
37.

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial.

Disertori M, Franzosi MG, Barlera S, Cosmi F, Quintarelli S, Favero C, Cappellini G, Fabbri G, Maggioni AP, Staszewsky L, Moroni LA, Latini R; GISSI-AF investigators.

BMC Cardiovasc Disord. 2013 Apr 15;13:28. doi: 10.1186/1471-2261-13-28.

38.

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Maggioni AP, Dahlström U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L; Heart Failure Association of the European Society of Cardiology (HFA).

Eur J Heart Fail. 2013 Jul;15(7):808-17. doi: 10.1093/eurjhf/hft050. Epub 2013 Mar 28.

39.

Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting.

Maggioni AP, Rossi E, Cinconze E, Roggeri DP, Roggeri A, Fabbri G, De Rosa M; ARNO Cardiovascular Observatory.

Cardiovasc Drugs Ther. 2013 Aug;27(4):333-40. doi: 10.1007/s10557-013-6455-z.

PMID:
23519685
40.

Outbreak of ampicillin/piperacillin-resistant Klebsiella pneumoniae in a neonatal intensive care unit (NICU): investigation and control measures.

Fabbri G, Panico M, Dallolio L, Suzzi R, Ciccia M, Sandri F, Farruggia P.

Int J Environ Res Public Health. 2013 Feb 26;10(3):808-15. doi: 10.3390/ijerph10030808.

41.

A review of the epidemiological profile of patients with atrial fibrillation and heart failure.

Fabbri G, Maggioni AP.

Expert Rev Cardiovasc Ther. 2012 Sep;10(9):1133-40. doi: 10.1586/erc.12.110. Review.

PMID:
23098149
42.

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.

Rossi D, Trifonov V, Fangazio M, Bruscaggin A, Rasi S, Spina V, Monti S, Vaisitti T, Arruga F, Famà R, Ciardullo C, Greco M, Cresta S, Piranda D, Holmes A, Fabbri G, Messina M, Rinaldi A, Wang J, Agostinelli C, Piccaluga PP, Lucioni M, Tabbò F, Serra R, Franceschetti S, Deambrogi C, Daniele G, Gattei V, Marasca R, Facchetti F, Arcaini L, Inghirami G, Bertoni F, Pileri SA, Deaglio S, Foà R, Dalla-Favera R, Pasqualucci L, Rabadan R, Gaidano G.

J Exp Med. 2012 Aug 27;209(9):1537-51. doi: 10.1084/jem.20120904. Epub 2012 Aug 13.

43.

Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.

Di Pasquale G, Mathieu G, Maggioni AP, Fabbri G, Lucci D, Vescovo G, Pirelli S, Chiarella F, Scherillo M, Gulizia MM, Gussoni G, Colombo F, Panuccio D, Nozzoli C, Berisso MZ; ATA-AF Investigators.

Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11.

PMID:
22884698
44.

Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.

Guardigni V, Fabbri G, Grilli A, Contini C.

Ann Hepatol. 2012 May-Jun;11(3):404-8.

45.

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

Rossi D, Fangazio M, Rasi S, Vaisitti T, Monti S, Cresta S, Chiaretti S, Del Giudice I, Fabbri G, Bruscaggin A, Spina V, Deambrogi C, Marinelli M, Famà R, Greco M, Daniele G, Forconi F, Gattei V, Bertoni F, Deaglio S, Pasqualucci L, Guarini A, Dalla-Favera R, Foà R, Gaidano G.

Blood. 2012 Mar 22;119(12):2854-62. doi: 10.1182/blood-2011-12-395673. Epub 2012 Feb 3.

46.

Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.

Scionti I, Fabbri G, Fiorillo C, Ricci G, Greco F, D'Amico R, Termanini A, Vercelli L, Tomelleri G, Cao M, Santoro L, Percesepe A, Tupler R.

J Med Genet. 2012 Mar;49(3):171-8. doi: 10.1136/jmedgenet-2011-100454. Epub 2012 Jan 3.

PMID:
22217918
47.

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Rossi D, Rasi S, Fabbri G, Spina V, Fangazio M, Forconi F, Marasca R, Laurenti L, Bruscaggin A, Cerri M, Monti S, Cresta S, Famà R, De Paoli L, Bulian P, Gattei V, Guarini A, Deaglio S, Capello D, Rabadan R, Pasqualucci L, Dalla-Favera R, Foà R, Gaidano G.

Blood. 2012 Jan 12;119(2):521-9. doi: 10.1182/blood-2011-09-379966. Epub 2011 Nov 10.

48.

Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy.

Staszewsky L, Wong M, Masson S, Raimondi E, Gramenzi S, Proietti G, Bicego D, Emanuelli C, Pulitanò G, Taddei F, Nicolis EB, Correale E, Fabbri G, Bertocchi F, Franzosi MG, Maggioni AP, Tognoni G, Disertori M, Latini R; GISSI-AF Investigators.

Circ Cardiovasc Imaging. 2011 Nov;4(6):721-8. doi: 10.1161/CIRCIMAGING.111.965954. Epub 2011 Sep 16.

PMID:
21926261
49.

Clinical characteristics of patients with asymptomatic recurrences of atrial fibrillation in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.

Disertori M, Lombardi F, Barlera S, Maggioni AP, Favero C, Franzosi MG, Lucci D, Staszewsky L, Fabbri G, Quintarelli S, Bianconi L, Latini R.

Am Heart J. 2011 Aug;162(2):382-9. doi: 10.1016/j.ahj.2011.05.008. Epub 2011 Jul 7.

PMID:
21835301
50.

Analysis of the coding genome of diffuse large B-cell lymphoma.

Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R.

Nat Genet. 2011 Jul 31;43(9):830-7. doi: 10.1038/ng.892.

Supplemental Content

Loading ...
Support Center